Tree of Life Synagogue in Pittsburgh. Photo: Brendan Smialowski/AFP via Getty Images

PayPal has cut ties with social networking service Gab following news that Pittsburgh gunman Robert Bowers — who killed 11 people at Tree of Life Synagogue on Saturday — had a history of using the platform for anti-Semitic speech, reports The Verge.

The big picture: Gab was founded in 2016 as a restriction-free alternative to Twitter, a social network that — while claiming "to defend free expression and individual liberty online for all people" — has attracted alt-right figures like Milo Yiannapolous and Richard Spencer that have been banned from other social media platforms.

The backdrop: This isn't the first time that Gab has come under scrutiny from tech companies for allowing hate speech to run unfiltered on its platform.

  • Apple has, on numerous occasions, refused to host Gab on its App Store for "objectionable content," including "references to religion, race, gender, sexual orientation, or other targeted groups that could be offensive to many users."
  • Google removed Gab from its Play Store in August 2017 for violating its hate speech policy, per The Verge.
  • In August 2018, Microsoft threatened to stop Gab from using its Azure cloud service after it received complaints about Gab posts that advocated ‘ritual death by torture’ and the ‘complete eradication’ of all Jews.

Seventeen days ago, a Gab account under Bowers' name posted a list of congregations that partner with HIAS, a refugee agency founded to provide aid to Jews, writing, "We appreciate the list of friends you have provided."

  • On Saturday morning, moments before entering the synagogue, Bowers posted,"HIAS likes to bring invaders in that kill our people. I can't sit by and watch my people get slaughtered. Screw your optics, I'm going in."

The bottom line: Gab issued a statement after the shooting saying it "unequivocally disavows and condemns all acts of terrorism and violence." But its founder has previously said the platform is "not going to police what is hate speech and what isn't," raising questions about whether both those claims can be true in the era of Big Tech.

Go deeper:

Go deeper

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 6 p.m. ET: 13,203,571 — Total deaths: 575,201 — Total recoveries — 7,331,068Map.
  2. U.S.: Total confirmed cases as of 6 p.m. ET: 3,407,798 — Total deaths: 136,252 — Total recoveries: 1,031,939 — Total tested: 41,004,275Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

2 hours ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."